NEW YORK ( TheStreet) -- Questcor Pharmaceuticals (Nasdaq: QCOR) hit a new 52-week high Monday as it is currently trading at $42.46, above its previous 52-week high of $42.43 with 349,658 shares traded as of 10:10 a.m. ET. Average volume has been 1.3 million shares over the past 30 days. Questcor has a market cap of $2.1 billion and is part of the health care sector and drugs industry. Shares are up 180.7% year to date as of the close of trading on Friday. Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription drugs for central nervous system disorders. The company's primary product is H.P. The company has a P/E ratio of 47.6, below the average drugs industry P/E ratio of 51.2 and above the S&P 500 P/E ratio of 17.7.
- Practice your QCOR trading strategies and win cash in our stock game.